FindTrial
Sign In

A study to determine the role of ankle brachial pressure index (index of blood pressure in the arms and legs )in diagnosing diabetic patients who have decreased blood flow in the lower limb blood vessels.

Role of Ankle Brachial Pressure Index in the early diagnosis of Peripheral Vascular Disease in asymptomatic diabetic patients - NIL

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
CTRI
Registry ID
CTRI/2024/05/067346
Enrollment
203
Registered
2024-05-15
Start date
Unknown
Completion date
Unknown
Last updated
2024-05-27

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: I73- Other peripheral vascular diseases

Interventions

Intervention1: NIL: NIL Control Intervention1: NIL: NIL

Sponsors

Dr Aishwarya Solanki
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1 All Type 2 diabetic patients from the OPD and wards in Dept of General Surgery & Dept of General Medicine who do not have PVD symptoms or signs like Active ulcers Absent peripheral pulses Intermittent Claudication Rest Pain Skin changes like cold, shiny skin Loss of hair on legs Thickened or opaque toe nails Gangrene 2 Previous healed ulcers 3 Patients giving consent to participate in the study. 4 Patients greater than 30 years of age. 5 Patients of both the genders. 6 Patients with peripheral neuropathy symptoms. 7 Patients with previous History of Myocardial Infarction, Stroke, TIA, CKD. 8 Patients with family history of arterial disease. 9 Smokers

Exclusion criteria

Exclusion criteria: 1 Type 2 Diabetic patients who have already developed any symptoms suggestive of PVD. 2 Patients lesser than 30 years of age. 3 Patients with previous amputations 4 Patients with active ulcers.

Design outcomes

Primary

MeasureTime frame
To Detect Peripheral Vascular Disease in asymptomatic diabetic patients using Ankle Brachial Pressure IndexTimepoint: The Ankle Brachial Pressure Index will be measured at the time of first contact with the patient in the OPD or ward, i.e. at Baseline only, which will take approximately 15-20 minutes. There will be no follow up of the patient.—

Secondary

MeasureTime frame
To determine prevalence of PVD among Asymptomatic Diabetic PatientsTimepoint: After the sample size is reached in 18 months , prevalence of PVD among the diabetic patient will be calculated.—

Countries

India

Contacts

Public ContactDr Vivek Ramesh Udupi

Department of General Surgery, Kasturba Medical College , Manipal

vijayendra.kedage@manipal.edu9844680445

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026